Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Partner Therapeutics Announces Trial to Evaluate Leukine® for COVID-19 Respiratory Illness

americanpharmaceuticalreviewMarch 30, 2020

Tag: Leukine , COVID-19 , Partner Therapeutics , GM-CSF

PharmaSources Customer Service